250 related articles for article (PubMed ID: 24260122)
1. Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial.
Ivory K; Wilson AM; Sankaran P; Westwood M; McCarville J; Brockwell C; Clark A; Dainty JR; Zuidmeer-Jongejan L; Nicoletti C
PLoS One; 2013; 8(11):e78650. PubMed ID: 24260122
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis.
Ivory K; Chambers SJ; Pin C; Prieto E; Arqués JL; Nicoletti C
Clin Exp Allergy; 2008 Aug; 38(8):1282-9. PubMed ID: 18510694
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
5. Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
Orban NT; Jacobson MR; Nouri-Aria KT; Durham SR; Eifan AO
Clin Exp Allergy; 2021 Feb; 51(2):329-338. PubMed ID: 33141493
[TBL] [Abstract][Full Text] [Related]
6. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
7. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
8. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
[TBL] [Abstract][Full Text] [Related]
9. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Spangler DL; Abelson MB; Ober A; Gotnes PJ
Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
[TBL] [Abstract][Full Text] [Related]
13. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
[TBL] [Abstract][Full Text] [Related]
14. Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial.
Mårtensson A; Nordström FU; Cervin-Hoberg C; Lindstedt M; Sakellariou C; Cervin A; Greiff L
Clin Exp Allergy; 2022 Jun; 52(6):774-783. PubMed ID: 35075723
[TBL] [Abstract][Full Text] [Related]
15. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
16. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
Pullerits T; Lindén A; Malmhäll C; Lötvall J
Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
[TBL] [Abstract][Full Text] [Related]
17. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
18. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5.
Beeh KM; Beier J; Kornmann O; Meier C; Taeumer T; Buhl R
Clin Exp Allergy; 2003 Apr; 33(4):475-82. PubMed ID: 12680863
[TBL] [Abstract][Full Text] [Related]
19. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
Greiff L; Persson CG; Svensson C; Enander I; Andersson M
J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
[TBL] [Abstract][Full Text] [Related]
20. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
